Bram Meijlink is a PhD candidate in the Therapeutic Ultrasound Contrast Agent Group which is part of the Department of Biomedical Engineering of the Thoraxcenter, Erasmus MC. He is working on his PhD Thesis under supervision of Associate Professor Klazina Kooiman and Prof. Dr. Antonius (Ton) F. W. van der Steen. During his PhD, Bram will focus on the mechanisms of microbubble-mediated vascular drug delivery, specifically the link between the microbubble oscillation, the vessel wall, and the drug. For his studies he will be using advanced in vitro models, like vessel-on-chip, and in vivo models to bring this microbubble-mediated therapy to patients.
Field(s) of expertise
- Microbubble-mediated drug delivery
- Ultrasound contrast agent (Microbubbles)
Education and career
Bram Meijlink obtained his B.Sc. degree Biomedical Sciences from Utrecht University, the Netherlands in 2016. He continued his university education with the research master program Regenerative Medicine and Technology at Utrecht University in cooperation with Eindhoven Technical University, the Netherlands. During his master, he performed a 12-month internship on cardiac regeneration in the University Medical Center (UMC) Utrecht, the Netherlands, followed by a 7-month internship on living myocardial slices at Imperial College London, United Kingdom. In 2019 he joined the Therapeutic Ultrasound Contrast Agent group in the Department of Biomedical Engineering at the Thoraxcenter, Erasmus MC.
Scholarships, grants, and awards
- Travel grant Fundatie van Renswoude
- Travel grant Hendrik Muller Fonds